Fertility after treatment for Hodgkin's disease

Annals of Oncology

Volumn 13, Issue SUPPL. 1, 2002, Pages 138-147

  Blumenfeld, Z ^a   Dann, E ^a   Avivi, I ^a   Epelbaum, R ^a   Rowe, J M ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Chemotherapy; GnRH analogs; Gonadotoxicity; Premature ovarian failure

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; CERAMIDE DERIVATIVE; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DACARBAZINE; DOXORUBICIN; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; INHIBIN A; INHIBIN B; LUTEINIZING HORMONE; PREDNISONE; PROCARBAZINE; PROLACTIN; PROTEIN BAX; PROTEIN BCL 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; TRIPTORELIN; VASCULOTROPIN; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; INHIBIN;

ADOLESCENT; ADULT; AMENORRHEA; ARTICLE; AUTOIMMUNE DISEASE; AUTOTRANSPLANTATION; AZOOSPERMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOPRESERVATION; DRUG FORMULATION; EMBRYO TRANSFER; FEMALE; FEMALE FERTILITY; FERTILIZATION IN VITRO; HODGKIN DISEASE; HUMAN; IMMUNOREACTIVITY; IN VITRO STUDY; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MENSTRUAL CYCLE; OVARY DEVELOPMENT; OVARY DISEASE; OVARY FOLLICLE; OVARY FUNCTION; PREPUBERTY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCTIVE TOXICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; XENOTRANSPLANTATION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FERTILITY; METABOLISM; METHODOLOGY; OOCYTE; ORGAN PRESERVATION; OVARY; PREMATURE OVARIAN FAILURE; REVIEW; TRANSPLANTATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CRYOPRESERVATION; FEMALE; FERTILITY; HODGKIN DISEASE; HUMANS; INHIBINS; ORGAN PRESERVATION; OVARIAN FAILURE, PREMATURE; OVARY; OVUM; TRIPTORELIN;

EID: 0036258161     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/13.S1.138     Document Type: Article

References (104)

1. Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonado-toxicity in young women
2. Prevention of gonadal damage during cytotoxic therapy
3. Debate: Ovarian banking for cancer patients-transmission of malignant cells in ovarian grafts
4. Oncological implications in the replacement of ovarian tissue
5. Reproductive factors in Hodgkin disease in women: A review
6. Recent progress in oocyte and ovarian tissue cryopreservation and transplantation
7. Limiting therapy for limited childhood non-Hodgkin's lymphoma
8. Curability of advanced Hodgkin's disease with chemotherapy
9. Effect of cytotoxic therapy on sexuality and gonadal function
10. Cytotoxic induced ovarian failure in women with Hodgkin's disease. I. Hormonal function
11. Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy of Hodgkin's disease
12. The relationship of gonadal damage to chemotherapy
13. Ovarian failure following abdominal irradiation in childhood
14. Prevention of chemotherapy-induced ovarian follicular loss in rats
15. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer
16. Gonadal function after MACOP-B or VACOP-B with or without dose intensification and ABMT in young patients with aggressive non-Hodgkin lymphoma
17. Long-term ovarian function evaluation after autografting by implantation with fresh and frozen-thawed human ovarian tissue
18. Fertility after treatment for cancer
19. Ethical issues in ovarian transplantation and donation
20. A critical evaluation of ovarian tissue cryopreservation and grafting as a strategy for preserving the human female germline
21. Gonadotrophin administration can benefit ovarian tissue grafted to the body wall: Implications for human ovarian grafting
22. Recent progress in oocyte tissue cryopreservation and transplantation
23. Cryopreservation of human ovarian tissue
24. Effect of a luteinizing hormone releasing hormone agonist given during combination chemotherapy on post-therapy fertility in male patients with lymphoma: Preliminary observations
25. Cytotoxic chemotherapy and gonadal function in patients with Hodgkin's disease
26. Administration of cyclophosphamide at different stages of follicular maturation in mice: Effects on reproductive performance and fetal malformations
27. Normal fertilization and development of frozen thawed mouse oocytes: Protective action of certain macromolecules
28. Cytogenetic analysis and developmental potential of vitrified mouse oocytes
29. Factors affecting low temperature survival of mammalian oocytes
30. Fertilization and development in humans
31. Cooling, cryoprotectants and the cytoskeleton of the mammalian oocyte
32. Production of embryos from in-vitro matured primary human oocytes
33. Gonadal cryopreservation in the young patient with gynaecological malignancy
34. Mechanism and management of gonadal failure in recipients of high dose chemoradiotherapy
35. Ovary transplanted to spleen in rats: The effect of unilateral castration, pregnancy and subsequent castration
36. Restoration of fertility to oophorectomized sheep by ovarian autografts stored at-196°C
37. The low temperature storage and grafting of human ovarian tissue into SCID mice
38. Assessment of oocyte survival in ovarian cortical grafts after frozen storage and xenografting
39. Fertility options for female cancer patients: Facts and fiction
40. Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to the graft recipient
41. Ovarian autografts in sheep as a model for studying folliculogenesis
42. Long-term ovarian function in sheep after ovariectomy and transplantation of autografts stored at -196°C
43. Ovarian function after transplantation of frozen, banked autologous ovarian tissue [letter]
44. Transplantation in reproductive medicine: Previous experience, present knowledge and future prospects
45. Will ovarian autotransplantation have a role in reproductive and gynecological medicine?
46. Subcutaneous autologous ovarian transplantation in Wistar rats maintains hormone secretion
47. Ovarian tissue cryopreservation: The time is now. Transplantation or in vitro maturation: The time awaits
48. Cryopreservation of human ovarian tissue using dimethylsulphoxide and propanediol-sucrose as cryoprotectants
49. Live births after autologous transplant of cryopreserved mouse ovaries
50. The future of ovarian cryopreservation and transplantation: Fertility and beyond
51. A model to test the safety of human ovarian tissue transplantation after cryopreservation: Xenografts of ovarian tissues from cancer patients into NOD/LtSz-Scid mice
52. Low temperature storage and grafting of human ovarian tissue
53. The significance of elevated basal follicle stimulating hormone in regularly menstruating infertile women
54. Female reproductive aging is marked by decreased secretion of dimeric inhibin
55. Preliminary experience with subcutaneous human ovarian cortex transplantation in to the NOD-SCID mouse
56. Human oocytes retrieval from nude mice transplanted with human ovarian cortex
57. Dynamics of follicular growth in the human: A model from preliminary results
58. Are there indications for ovarian tissue cryopreservation?
59. Orthotopic and heterotopic autografts of frozen thawed ovarian cortex in sheep
60. Immature rat ovaries become revascularized rapidly after autotransplantation and show a gonadotropin-dependent increase in angiogenic factor gene expression
61. Failure to preserve fertility in patients with Hodgkin's disease
62. Protection from cyclophosphamide induced testicular damage with an analogue of gonadotropin-releasing hormone
63. The effects of chemotherapy and radio-therapy on fertility and their prevention
64. Chemotherapy during pregnancy
65. Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide induced ovarian follicular depletion in Rhesus monkeys
66. Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotropin-releasing hormone agonist in parallel to chemotherapy
67. Inhibin-A concentrations in sera of young women during and following chemotherapy for lymphoma-correlation with ovarian toxicity
68. Cancer Statistics, 19137
69. Long-term gonadal dysfunction and its impact on bone mineralization in patients following COPP/ABVD chemotherapy for Hodgkin's disease
70. Ovarian rescue/protection from chemotherapeutic agents
71. Bone mineral density (BMD) in patients with lymphoma: The effects of chemotherapy, intermittent corticosteroids and premature menopause
72. Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: The Stanford experience
73. Chemotherapy and ovarian function. Retrospective analysis in 17 girls treated for malignant tumor of hematologic disease
74. Ovarian function following the treatment of childhood acute lymphoblastic leukemia
75. Gonadal toxicity following cancer therapy in adults: Significance, diagnosis, prevention and treatment
76. Treatment with the gonadotropin-releasing hormone agonist buserelin to protect spermatogenesis against cytotoxic treatment in young men
77. Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer
78. The agonist (d-leu-6,des-gly-10)-LHRH-ethylamide does not protect the fecundity of rats exposed to high dose unilateral ovarian irradiation
79. Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: A preliminary report
80. A comparison of observational studies and randomized, controlled trials
81. Randomized, controlled trials, observational studies and the hierarchy of research designs
82. High-dose chemoradiotherapy followed by autologous bone marrow transplantation as a consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: A pilot study
83. Autologous bone marrow transplantation for high grade lymphoid malignancy using melphalan/irradiation conditioning without bone marrow purging or cryopreservation
84. Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation
85. Long-term endocrine toxicity of myeloablative treatment followed by autologous bone marrow/blood derived stem cell transplantation in patients with malignant lymphohematopoietic disorders
86. Ovarian function following marrow transplantation for aplastic anaemia or leukaemia
87. Fertility, pregnancies and offspring complications after bone marrow transplantation
88. Clinical aspects of LHRH analogues in gynecology: A review
89. The effect of cyclophosphamide pulses on fertility in patients with lupus nephritis
90. Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy
91. Growth hormone-binding protein regulation by estrogen, progesterone, and gonadotropins in human: The effect of ovulation induction with menopausal gonadotropins, GH and gestation
92. Commuting the death sentence: How oocytes strive to survive
93. Protection of the ovary from radiation-induced damage by small molecule therapy in-vivo
94. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy
95. Apoptosis associated signaling pathways are required for chemotherapy-mediated female germ cell destruction
96. Cell death genes may hold clues to preserving fertility after chemotherapy
97. Targeted expression of Bcl-2 in mouse oocytes inhibits ovarian follicle atresia and prevents spontaneous and chemotherapy-induced oocyte apoptosis in vitro
98. Bax-induced cell death may not require interleukin-1β converting enzyme like proteases
99. Regulation of ceramide production and apoptosis
100. Ceramide enables Fas to cap and kill
101. Functional consequences of the sustained or transient activation by Bax of the mitochondrial permeability transition pore
102. Suppression of ceramide-mediated programmed cell death by sphingosine-1 phosphate
103. Sphingosine-1 phosphate in cell growth and death
104. Suppression of oocyte apoptosis by sphingosine-1 phosphate therapy in vivo preserves fertility following radiotherapy